Catalyst Wire Dossier Catalyst Wire Dossier

H2 antagonist

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H2 antagonist, covering 2024-10-30 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants [Phase 1]

See pricing